Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003Astri Fjelde Maaland, Jostein Dahle, Helèn Heyerdahl et al.|PLoS ONE|2020Cited by 39
Targeted Alpha Therapy with 212Pb-NNV003 for the Treatment of CD37 Positive B-Cell Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)Amal Saidi, Jostein Dahle, Astri Fjelde Maaland et al.|Blood|2018Cited by 5
Abstract 5432: Targeted alpha therapy with 212Pb-NNV003 in treatment of NHLJostein Dahle, Julien Torgue, Amal Saidi et al.|Cancer Research|2022Cited by 1
Targeted alpha therapy with 212Pb-NNV003 for the treatment of CD37 positive B-cell chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL)Amal Saidi, Jostein Dahle, Helèn Heyerdahl et al.|Unknown|2019Cited by 0